首页 | 本学科首页   官方微博 | 高级检索  
检索        

依达拉奉治疗血管性帕金森综合征的疗效观察
引用本文:王冰.依达拉奉治疗血管性帕金森综合征的疗效观察[J].中国实用神经疾病杂志,2007,10(9):45-46.
作者姓名:王冰
作者单位:郑州大学公共卫生学院,郑州,450000
摘    要:目的 评定依达拉奉治疗血管性帕金森综合征的临床疗效.方法 入选85例病人,随机分为治疗组45例、对照组40例,2组病人诊断符合血管性帕金森综合征的诊断标准,年龄、性别、症状、体征及病程等具有可比性.对照组给予美多巴片,疗程12周;治疗组给予依达拉奉注射液、美多巴片,疗程12周.12周后观察临床疗效.结果 依达拉奉组疗效明显优于美多巴组.结论 依达拉奉治疗血管性帕金森综合征效果满意,有应用价值.

关 键 词:血管性帕金森综合征  依达拉奉  美多巴  疗效观察  依达拉奉注射液  治疗组  血管性帕金森综合征  疗效观察  vascular  价值  应用  效果满意  多巴组  疗效明显  结果  美多巴片  可比  病程  性别  年龄  诊断标准  诊断符合  对照组  随机
文章编号:1673-5110(2007)09-0045-02
修稿时间:2007年10月8日

Effect of Edaravone on treating vascular parkinsonism
Wang Bing.Effect of Edaravone on treating vascular parkinsonism[J].Chinese Journal of Practical Neruous Diseases,2007,10(9):45-46.
Authors:Wang Bing
Abstract:Objective To assess the curative effect of Edaravone in the treatment of vascular parkinsonism.Methods In a randomized trial,85 patients without contraindication were divided into treatment group(45 patients treated with Edaravone injection 80mg,qd,and routine therapy) and control group(40 patients treated with routine therapy,Madopar,qd,po),there were comparabilities with general condition before treatment between the two groups above.Results After treatment,control group's UPDRS evidently decreased(P<0.05).Conclusion Edaravone can provide a satisfactory treatment for patients with vascular parkinsonism.
Keywords:Vascular parkinsonism  Edaravone  Madopar  Curative effect
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号